Outlook for 2011

Published on 25 October 2011

Net sales will be slightly higher than in 2010.

Marketing expenditure will be higher due to the increased number of product launches. Research expenditure will be higher than in 2010.

Operating profit excluding non-recurring items will be higher than in 2010.

The Group’s capital expenditure will be about EUR 45 million excluding substantial corporate or product acquisitions.

Published on 2 August 2011

Net sales will be slightly higher than in 2010.

Marketing expenditure will be higher due to the increased number of product launches. Research expenditure will be higher than in 2010.

Operating profit excluding non-recurring items will be higher than in 2010.

The Group’s capital expenditure will be about EUR 45 million excluding substantial corporate or product acquisitions.

Published on 27 April 2011

Net sales will be slightly higher than in 2010.

Marketing expenditure will be higher due to the increased number of product launches. Research expenditure will be higher than in 2010.

Operating profit excluding non-recurring items will be higher than in 2010.

The Group’s capital expenditure will be about EUR 45 million excluding substantial corporate or product acquisitions.

Published on 14 April 2011

Net sales will be slightly higher than in 2010.

Marketing expenditure will be higher due to the increased number of product launches. Research expenditure will be higher than in 2010.

Operating profit excluding non-recurring items will be higher than in 2010.

The Group’s capital expenditure will be about EUR 45 million excluding substantial corporate or product acquisitions.

Published on 9 February 2011

Net sales will be slightly higher than in 2010.

Marketing expenditure will be slightly higher due to the increased number of product launches. Research expenditure will be clearly higher than in 2010.

Operating profit excluding non-recurring items will be slightly higher than in 2010.

The Group’s capital expenditure will be about EUR 45 million excluding substantial corporate or product acquisitions.